Your ~2K for precomplexed afm13-cbNK is in agreement with company estimate on cHL. Pricing is same as CAR-T initially according to company per discussion with coverage specialists last year. Each billion cell dose current manufacturing cost is $1300 for cbNK portion. Don't have cost data on afm13 yet. In MDACC run trial, each patient at rp2d is getting around ~7B cells per cycle.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.